Why the study?
Does chronic baroreflex activation or renal denervation restore cardiovascular dynamic control in dogs with obesity-induced hypertension?
Does chronic baroreflex activation or renal denervation restore cardiovascular dynamic control in dogs with obesity-induced hypertension?
Answers are grounded in this paper and cite their sources.
In a canine model of obesity-induced hypertension, chronic baroreflex activation, unlike renal denervation, not only lowers blood pressure but also restores heart rate variability and baroreflex sensitivity, potentially reducing arrhythmia risk.
The sensitivity of baroreflex control of heart rate is depressed in subjects with obesity hypertension, which increases the risk for cardiac arrhythmias. The mechanisms are not fully known, and there are no therapies to improve this dysfunction. To determine the cardiovascular dynamic effects of progressive increases in body weight leading to obesity and hypertension in dogs fed a high-fat diet, 24-h continuous recordings of spontaneous fluctuations in blood pressure and heart rate were analyzed in the time and frequency domains. Furthermore, we investigated whether autonomic mechanisms stimulated by chronic baroreflex activation and renal denervation-current therapies in patients with resistant hypertension, who are commonly obese-restore cardiovascular dynamic control. Increases in body weight to ∼150% of control led to a gradual increase in mean arterial pressure to 17 ± 3 mmHg above control (100 ± 2 mmHg) after 4 wk on the high-fat diet. In contrast to the gradual increase in arterial pressure, tachycardia, attenuated chronotropic baroreflex responses, and reduced heart rate variability were manifest within 1-4 days on high-fat intake, reaching 130 ± 4 beats per minute (bpm) (control = 86 ± 3 bpm) and ∼45% and <20%, respectively, of control levels. Subsequently, both baroreflex activation and renal denervation abolished the hypertension. However, only baroreflex activation effectively attenuated the tachycardia and restored cardiac baroreflex sensitivity and heart rate variability. These findings suggest that baroreflex activation therapy may reduce the risk factors for cardiac arrhythmias as well as lower arterial pressure.
No takes yet. Share an insight, caveat, or question.
Iliescu et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: